Big Deals

Aetna/Coventry; BC Partners and CPP Investment Board/Suddenlink; NRG/GenOn

, The American Lawyer

   |0 Comments

Aetna/Coventry

Aetna Inc. agreed to pay $5.7 billion in cash and stock for health insurer Coventry Health Care Inc. on August 20. The buyer will also assume $1.7 billion in Coventry debt, giving the deal a total value of $7.3 billion. The target's shareholders will receive $27.30 in cash and 0.3885 Aetna shares per Coventry share, consideration worth $42.08, a 20 percent premium to Coventry's closing price on August 17, the last trading day before the deal was announced. The deal would be the largest that Aetna has signed up since it completed a major reorganization in 2000 by selling its financial services and international businesses to ING Groep N.V. for $7.7 billion.

The acquisition would bolster Aetna's ability to provide government-supported health care plans, and the market applauded the deal, bidding Aetna's stock up by 4 percent on the news. WellPoint Inc. was motivated by the same goal in agreeing to buy managed care company Amerigroup Corporation for $4.9 billion in cash on July 9 [see Deals in Brief]. Aetna and Coventry hope to close the deal by the middle of next year, pending approvals by regulators and Coventry shareholders.

For acquiror Aetna Inc. (Hartford)

In-House: General counsel William Casazza, head of corporate legal group Michelle Matiski, senior corporate counsel William Baskin, counsel Traci Kosak and Adam McAnaney, corporate secretary Judith Jones, chief Medicare counsel Christine Rinn, and chief Medicaid counsel Robert Kessler.

Davis Polk & Wardwell: Corporate: David Caplan, H. Oliver Smith, counsel Ajay Lele, and asso­ciates Lee Hochbaum and Evan Rosen. Executive compensation and employee benefits: Edmond FitzGerald and asso­ciate Jennifer Freiman. Tax: Harry Ballan and associate William Curran. Credit: Jason Kyrwood and associate Darren Mahone. (All are in New York.) Davis Polk is longtime counsel to Aetna. The firm represented Aetna last year on several deals, including its $202 million purchase of PayFlex Holdings Inc.; its $290 million purchase of Genworth Financial Inc.'s Medicare supplement business; and its $600 million purchase of Prodigy Health Group Inc. from One Equity Partners. And in 2010 Davis Polk represented Aetna on its $500 million acquisition of Medicity Inc. Davis Polk also represented Aetna on the ING deal.

Jones Day: Antitrust: Phillip Proger, Margaret "Peggy" Ward, and associate Ausra Deluard. (Proger is in Washington, D.C. Ward is in Palo Alto. Deluard is in San Francisco.)

Locke Lord: Insurance regulatory: Jon Biasetti, Elizabeth Tosaris, Paige Waters, and senior counsel Timothy Farber, Jay Kallas, and Jan Reimann Newsom. (All are in Chicago except for San Francisco–based Tosaris and Dallas-based Newsom.) Both Jones Day and Locke Lord have advised Aetna for many years.

Manatt, Phelps & Phillips: Medicare and Medicaid managed care regulatory: Wendy Krasner. New York state health care regulatory: Mark Ustin. Health care corporate: Bruce Wolff and associates Karen Lam and Emily Lee. (All are in Washington, D.C., except for Albany-based Ustin and New York–based Lee.)

For target Coventry Health Care Inc. (Bethesda, Maryland)

In-House: General counsel Thomas Zielinski and deputy general counsel Jonathan Weinberg.

Wachtell, Lipton, Rosen & Katz: Corporate: David Katz and asso­ciate Donald Casey. Antitrust: Ilene Knable Gotts and asso­ciate Lori Sherman. Tax: Deborah Paul and associate Rachel Reisberg. Executive compensation and benefits: Jeremy Goldstein and associate D. Miishe Addy. Finance: Eric Rosof and asso­ciates Gregory Pessin and Austin Witt. (All are in New York.)

Bass, Berry & Sims: Corporate: Bob Thompson and senior asso­ciate Price Wilson. Health care M&A: Angela Humphreys and J. James Jenkins Jr. Antitrust: R. Dale Grimes. Tax: R. Todd Ervin. (All are in Nashville.) Thompson introduced Wachtell's Katz to the client many years ago and with Coventry GC Zielinski called him again when Aetna first approached Coventry.

Bass Berry began working for Coventry in the 1990s when the company was still headquartered in Nashville, prior to its move to Bethesda. The firm has represented the company on more than two dozen health plan transactions, including the 1998 merger with Principal Health Care Inc. The firm also counseled Coventry on its $685 million purchase of Florida Health Plan Administrators LLC in 2007 and on its $1.8 billion acquisition of First Health Group Corp. three years earlier.

Crowell & Moring: Antitrust: Arthur Lerner, counsel Shawn Johnson and Barbara Ryland, and associates Elliot Golding and Lauren Patterson. (All are in Washington, D.C.) The firm is Coventry's regular antitrust counsel.

Potter Anderson & Corroon: Corporate: Mark Morton and associate Pamela Millard. Litigation: Donald Wolfe Jr. (All are in Wilmington.) Wachtell's Katz tapped Morton as Delaware counsel on the deal. Coventry is incorporated in the state.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202572357449

Thank you!

This article's comments will be reviewed.